Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where V. V. Filonenko is active.

Publication


Featured researches published by V. V. Filonenko.


The EMBO Journal | 2000

Negative regulation of PI 3-kinase by Ruk, a novel adaptor protein.

Ivan Gout; Gayle Middleton; Jimi Adu; Natalia Ninkina; Ludmila B. Drobot; V. V. Filonenko; Gennady Matsuka; Alun M. Davies; Michael D. Waterfield; Vladimir L. Buchman

Class IA phosphatidylinositol 3‐kinase (PI 3‐kinase) is a key component of important intracellular signalling cascades. We have identified an adaptor protein, Rukl, which forms complexes with the PI 3‐kinase holoenzyme in vitro and in vivo. This interaction involves the proline‐rich region of Ruk and the SH3 domain of the p85α regulatory subunit of the class IA PI 3‐kinase. In contrast to many other adaptor proteins that activate PI 3‐kinase, interaction with Rukl substantially inhibits the lipid kinase activity of the enzyme. Overexpression of Rukl in cultured primary neurons induces apoptosis, an effect that could be reversed by co‐expression of constitutively activated forms of the p110α catalytic subunit of PI 3‐kinase or its downstream effector PKB/Akt. Our data provide evidence for the existence of a negative regulator of the PI 3‐kinase signalling pathway that is essential for maintaining cellular homeostasis. Structural similarities between Ruk, CIN85 and CD2AP/CMS suggest that these proteins form a novel family of adaptor molecules that are involved in various intracellular signalling pathways.


Journal of Biological Chemistry | 1998

Molecular cloning and characterization of a novel p70 S6 kinase, p70 S6 kinase beta containing a proline-rich region.

Ivan Gout; Taichi Minami; Kenta Hara; Yosuke Tsujishita; V. V. Filonenko; Michael D. Waterfield; Kazuyoshi Yonezawa

A novel ribosomal S6 kinase, termed p70 S6 kinase β (p70β), which has a highly conserved amino acid sequence compared with that of p70/p85 S6 kinase (p70α) within the catalytic, kinase extension, and autoinhibitory pseudosubstrate domains, was identified. However, the amino acid sequence of p70β differs from that of p70α in the noncatalytic amino-terminal region and in the carboxyl-terminal tail, which contains a proline-rich region. The majority of the regulatory phosphorylation sites identified in p70α are conserved in p70β. Two isoforms of p70β, referred to as β1 (495 amino acids) and β2 (482 amino acids), could be expressed from the single gene either by alternative mRNA splicing or by the use of alternative start codons. Here we report the characterization of p70β2. Similarly to p70α, the catalytic activity of p70β toward ribosomal protein S6 could be rapidly activated by serum, insulin, and phorbol ester in transiently transfected cells. The p70β kinase was found to be significantly less sensitive to wortmannin and rapamycin than p70α. These results indicate that p70β has the potential to participate in the regulation of protein synthesis and the cell cycle.


Leukemia Research | 2006

PRAME is a membrane and cytoplasmic protein aberrantly expressed in chronic lymphocytic leukemia and mantle cell lymphoma

Rodrigo Proto-Siqueira; Lorena Lobo de Figueiredo-Pontes; Rodrigo A. Panepucci; Aglair B. Garcia; Edgar G. Rizzatti; Fabio M. Nascimento; Hellen C.F. Ishikawa; Roy E. Larson; Roberto P. Falcao; Andrew J.G. Simpson; Ivan Gout; V. V. Filonenko; Eduardo M. Rego; Marco A. Zago


Archive | 2000

Nucleic acid molecules associated with melanoma and thyroid tumors

Ivan Gout; Nikolay Rodnin; V. V. Filonenko; Genadiy Matsuka; Matthew J. Scanlan; Lloyd Old; Boris Bilynsky


Biopolymers & Cell | 2010

Novel antibodies against RCD-8 as a tool to study processing bodies

D. O. Gudkova; Ganna Panasyuk; Ivan Nemazanyy; V. V. Filonenko


Biopolymers & Cell | 2009

CoA Synthase influences adherence-independent growth and survival of mammalian cells in vitro

O. S. Breus; Ivan Nemazanyy; Ivan Gout; V. V. Filonenko; Ganna Panasyuk


Biopolymers & Cell | 2005

The beta subunit of casein kinase 2 as a novel binding partner of the ribosomal protein S6 kinase 1

Ganna Panasyuk; I. O. Nemzanyy; A. M. Zhyvoloup; V. V. Filonenko; Ivan Gout


Biopolymers & Cell | 2007

Interaction of serine/threonine protein phosphatase 5 with the protein products of tumour suppressor gene Tsc2

O. M. Malanchuk; S. S. Palchevskyy; V. K. Pozur; Ivan Gout; V. V. Filonenko


Biopolymers & Cell | 2000

Search and characterization of melanoma antigens with the use of serological identification of antigens by recombinant expression cloning

M. V. Rodnin; I. O. Tykhonkova; V. V. Filonenko; Ludmila B. Drobot; G. Kh. Matsuka; Ivan Gout


Biopolymers & Cell | 2000

The immunochemical cross-reactivity between cytoplasmic and mitochondrial mammalian lysyl-tRNA synthetases

L. L. Sidorik; T. A. Rybkinska; N. G. Bakhiya; N. V. Rodnin; V. V. Filonenko; N. S. Entelis; I. A. Tarassov; R. P. Martin; G. Kh. Matsuka

Collaboration


Dive into the V. V. Filonenko's collaboration.

Top Co-Authors

Avatar

Ivan Gout

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Ganna Panasyuk

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Ivan Nemazanyy

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marco A. Zago

University of São Paulo

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D. O. Gudkova

Taras Shevchenko National University of Kyiv

View shared research outputs
Top Co-Authors

Avatar

Ludmila B. Drobot

National Academy of Sciences of Ukraine

View shared research outputs
Top Co-Authors

Avatar

O. M. Malanchuk

Taras Shevchenko National University of Kyiv

View shared research outputs
Researchain Logo
Decentralizing Knowledge